<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01150591</url>
  </required_header>
  <id_info>
    <org_study_id>F32HL097383</org_study_id>
    <nct_id>NCT01150591</nct_id>
  </id_info>
  <brief_title>Microaspiration in Pulmonary Fibrosis</brief_title>
  <acronym>ROMI</acronym>
  <official_title>The Role of Microaspiration in Idiopathic Pulmonary Fibrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis 1: Microaspiration, as diagnosed by bronchoalveolar lavage (BAL) pepsin, is common
      in patients with IPF.

      Hypothesis 2a: Baseline clinical variables and co-morbid conditions are risk factors for
      microaspiration in patients with IPF.

      Hypothesis 2b: Baseline biological variables reflecting alveolar epithelial injury and
      inflammation are markers of microaspiration in IPF.

      Hypothesis 3a: Microaspiration will lead to a more rapid rate of decline in pulmonary
      function.

      Hypothesis 3b: Microaspiration will lead to higher rates of urgent medical care use (i.e.
      unscheduled clinic visit, emergency room visit, or hospitalization).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>BAL pepsin level</measure>
    <time_frame>Cross sectional</time_frame>
  </primary_outcome>
  <enrollment type="Actual">20</enrollment>
  <condition>Idiopathic Pulmonary Fibrosis</condition>
  <biospec_descr>
    <textblock>
      This is a prospective cohort study of patients with IPF. Subjects will undergo (1) an
      assessment of the presence or absence of microaspiration (via bronchoscopy and BAL pepsin
      level), (2) measurement of biomarkers of microaspiration (via esophageal function studies,
      laboratory tests, pulmonary function, chest imaging, and survey), and (3) longitudinal
      follow-up to document disease progression (via pulmonary function and survey).
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with IPF
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of IPF

          -  Ability ot provide informed consent

        Exclusion Criteria:

          -  History of fundoplication or other gastroesophageal surgery

          -  Too ill to undergo bronchoscopy in the opinion of the investigator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 23, 2010</study_first_submitted>
  <study_first_submitted_qc>June 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2010</study_first_posted>
  <last_update_submitted>December 1, 2015</last_update_submitted>
  <last_update_submitted_qc>December 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

